ASKA Pharmaceutical Holdings Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 17.08% vs 1.38% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 59.12% vs -7.73% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "16,641.00",
          "val2": "14,213.00",
          "chgp": "17.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,714.00",
          "val2": "429.00",
          "chgp": "299.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "60.00",
          "val2": "16.00",
          "chgp": "275.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-244.00",
          "val2": "-300.00",
          "chgp": "18.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,596.00",
          "val2": "1,003.00",
          "chgp": "59.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "55.40%",
          "val2": "-11.50%",
          "chgp": "6.69%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 10.90% vs 2.06% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 10.27% vs -32.39% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "71,127.00",
          "val2": "64,139.00",
          "chgp": "10.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8,919.00",
          "val2": "7,580.00",
          "chgp": "17.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "222.00",
          "val2": "51.00",
          "chgp": "335.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-148.00",
          "val2": "-300.00",
          "chgp": "50.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5,625.00",
          "val2": "5,101.00",
          "chgp": "10.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "82.00%",
          "val2": "83.10%",
          "chgp": "-0.11%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

16,641.00

14,213.00

17.08%

Operating Profit (PBDIT) excl Other Income

1,714.00

429.00

299.53%

Interest

60.00

16.00

275.00%

Exceptional Items

-244.00

-300.00

18.67%

Consolidate Net Profit

1,596.00

1,003.00

59.12%

Operating Profit Margin (Excl OI)

55.40%

-11.50%

6.69%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 17.08% vs 1.38% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 59.12% vs -7.73% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

71,127.00

64,139.00

10.90%

Operating Profit (PBDIT) excl Other Income

8,919.00

7,580.00

17.66%

Interest

222.00

51.00

335.29%

Exceptional Items

-148.00

-300.00

50.67%

Consolidate Net Profit

5,625.00

5,101.00

10.27%

Operating Profit Margin (Excl OI)

82.00%

83.10%

-0.11%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is 10.90% vs 2.06% in Mar 2025

Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 10.27% vs -32.39% in Mar 2025

All Annual Results